Our HTGF Portfolio of startups offers excellent opportunities and is always hiring talented people.
Locations
Straßlach-Dingharting, Germany
industry
Health · Medical Devices
Size
1 - 10 employees
founded in
2021
Sedivention develops a break-through, widely applicable device for interventional obesity therapy. Hunger is transmitted from the stomach to the brain by the gastric trunks of the vagal nerve. Sedivention is developing a cryo-balloon freezing the gastric branches of the vagal nerve from inside the stomach, in a procedure comparable to gastroscopy. The ambulatory intervention takes approximately 20 minutes. The costs of the intervention are far below the costs of bariatric surgery without surgical morbidity and complications. In brief, Sedivention develops the first long-term effective, scalable therapy for obesity: no scars, no pain, no surgical complications, no access barriers at an affordable price. Obesity causes over 400,000 deaths yearly in the US alone and costs of more than 2.0 trillion USD worldwide. According to the WHO Obesity Atlas 2022, there will be 1 billion obese persons worldwide in 2030.
Something looks off?